Swedbank’s PRA Health Sciences, Inc. PRAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-252,900
Closed -$25.1M 116
2019
Q3
$25.1M Sell
252,900
-569,200
-69% -$56.5M 0.11% 101
2019
Q2
$81.5M Buy
822,100
+56,000
+7% +$5.34M 0.37% 88
2019
Q1
$84.5M Sell
766,100
-65,313
-8% -$6.83M 0.4% 81
2018
Q4
$73.9M Sell
831,413
-119,687
-13% -$12.1M 0.41% 81
2018
Q3
$105M Buy
+951,100
New +$99M 0.47% 75

Other funds holding PRAH

Swedbank's PRAH Position: Q4 2019 in Review

Swedbank sold out of PRA Health Sciences, Inc. (PRAH) in Q4 2019, closing a stake of 252,900 shares — an estimated $25.1M sold.

Swedbank first reported a position in PRAH in Q3 2018 and held it in 5 quarters. The position peaked at $105M in Q3 2018. 345 funds tracked by Wall St. Rank hold PRAH as of Q4 2019.

  • Swedbank reported no remaining PRA Health Sciences, Inc. position as of Q4 2019 after selling out during the quarter.
  • Swedbank sold 252,900 PRA Health Sciences, Inc. shares in Q4 2019, an estimated $25.1M.
  • Swedbank first reported a position in PRA Health Sciences, Inc. in Q3 2018 and held it in 5 quarters.
  • Swedbank's PRA Health Sciences, Inc. position peaked at $105M in Q3 2018.
  • 345 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q4 2019.

Based on Swedbank's 13F filing for Q4 2019, filed 14 Feb 2020.